Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 4896036, 7 pages
https://doi.org/10.1155/2017/4896036
Clinical Study

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema

1Department of Medical Science, Neuroscience and Sense Organs, Eye Clinic, University of Bari, Bari, Italy
2Department of Surgical, Microsurgical and Medical Sciences, Eye Clinic, University of Sassari, Sassari, Italy
3Eye clinic, University of Catania, Catania, Italy

Correspondence should be addressed to Alfredo Niro; ti.ilacsit@rin.derfla

Received 21 May 2017; Revised 11 July 2017; Accepted 31 July 2017; Published 13 August 2017

Academic Editor: Lisa Toto

Copyright © 2017 Claudio Furino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. G. Obrosova, S. S. Chung, and P. F. Kador, “Diabetic cataracts: mechanisms and management,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 172–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. M. Haddad, J. K. Sun, S. Abujaber, D. K. Schlossman, and P. S. Silva, “Cataract surgery and in diabetic its complications patients,” Seminars in Ophthalmology, vol. 29, no. 5-6, pp. 329–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Kim, R. Equi, and N. M. Bressler, “Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography,” Ophthalmology, vol. 114, no. 5, pp. 881–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Suto, S. Hori, and S. Kato, “Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery,” Journal of Cataract and Refractive Surgery, vol. 34, no. 6, pp. 1001–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. W. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. P. I. Rauen, J. A. S. Ribeiro, F. P. P. Almeida, I. U. Scott, A. Messias, and R. Jorge, “Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema,” Retina, vol. 32, no. 9, pp. 1799–1803, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Lanzagorta-Aresti, E. Palacios-Pozo, J. L. Menezo Rozalen, and A. Navea-Tejerina, “Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study,” Retina, vol. 29, no. 4, pp. 530–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Takamura, E. Kubo, and Y. Akagi, “Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery,” Ophthalmology, vol. 116, no. 6, pp. 1151–1157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Akinci, C. Batman, E. Ozkilic, and A. Altinsoy, “Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract,” Retina, vol. 29, no. 10, pp. 1432–1435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Chen, Y. C. Liu, and P. C. Wu, “The combination of intravitreal bevacizumab and phacoemulsification surgery in patients with cataract and coexisting diabetic macular edema,” Journal of Ocular Pharmacology and Therapeutics, vol. 25, no. 1, pp. 83–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Habib, P. S. Cannon, and D. H. Steel, “The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabetic foveal oedema and cataract,” BMC Ophthalmology, vol. 5, p. 15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Akinci, O. Muftuoglu, A. Altınsoy, and E. Ozkılıc, “Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract,” Retina, vol. 31, no. 4, pp. 755–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. L. Lim, J. L. Morrison, M. Constantinou et al., “Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results,” Clinical and Experimental Ophthalmology, vol. 44, no. 4, pp. 233–242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Agarwal, V. Gupta, J. Ram, and A. Gupta, “Dexamethasone intravitreal implant during phacoemulsification,” Ophthalmology, vol. 120, no. 1, p. 211, 2013, 211.e1-5. View at Publisher · View at Google Scholar · View at Scopus
  15. G. A. Panozzo, E. Gusson, G. Panozzo, and M. G. Dalla, “Dexamethasone intravitreal implant at the time of cataract surgery in eyes with diabetic macular edema,” European Journal of Ophthalmology, vol. 27, no. 4, pp. 433–437, 2017. View at Publisher · View at Google Scholar
  16. A. M. Sze, F. O. Luk, T. P. Yip, G. K. Lee, and C. K. Chan, “Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification,” European Journal of Ophthalmology, vol. 25, no. 2, pp. 168–172, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. “Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group,” Archives of Ophthalmology, vol. 103, no. 12, pp. 1796–1806, 1985. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Koleva-Georgieva, “Optical coherence tomography findings in diabetic macular edema,” in Diabetic Retinopathy, M. S. Ola, Ed., InTech, Vienna, Austria, 2012. View at Publisher · View at Google Scholar
  19. A. S. Shah and S. H. Chen, “Cataract surgery and diabetes,” Current Opinion in Ophthalmology, vol. 21, no. 1, pp. 4–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Squirrell, R. Bhola, J. Bush, S. Winder, and J. F. Talbot, “A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes,” The British Journal of Ophthalmology, vol. 86, no. 5, pp. 565–571, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Somaiya, J. D. Burns, R. Mintz, R. E. Warren, T. Uchida, and B. F. Godley, “Factors affecting visual outcomes after small-incision phacoemulsification in diabetic patients,” Journal of Cataract and Refractive Surgery, vol. 28, no. 8, pp. 1364–1371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Gillies, L. L. Lim, A. Campain et al., “A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study,” Ophthalmology, vol. 121, no. 12, pp. 2473–2481, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Furino, F. Boscia, N. Recchimurzo, C. Sborgia, and G. Alessio, “Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification,” European Journal of Ophthalmology, vol. 24, no. 3, pp. 387–391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Furino, F. Boscia, N. Recchimurzo, C. Sborgia, and G. Alessio, “Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker,” Retina, vol. 34, no. 8, pp. 1612–1616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. J. E. Chang-Lin, M. Attar, A. A. Acheampong et al., “Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant,” Investigative Ophthalmology & Visual Science, vol. 52, no. 1, pp. 80–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Feltgen, A. Neubauer, B. Jurklies et al., “Multicenter study of the European Assessment Group for Lysin in Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no.1,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 244, no. 8, pp. 950–956, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. S. Blumenkranz, J. A. Haller, B. D. Kuppermann et al., “Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema,” Retina, vol. 30, no. 7, pp. 1090–1094, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Diabetic Retinopathy Clinical Research Network, D. J. Browning, A. R. Glassman et al., “Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema,” Ophthalmology, vol. 114, no. 3, pp. 525–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. G. H. Bresnick, “Diabetic maculopathy: a critical review highlighting diffuse macular edema,” Ophthalmology, vol. 90, no. 11, pp. 1301–1317, 1983. View at Publisher · View at Google Scholar
  30. M. L. Nelson and A. Martidis, “Managing cystoids macular edema after cataract surgery,” Current Opinion in Ophthalmology, vol. 14, pp. 39–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Massin, F. Audren, B. Haouchine et al., “Intravitreal triamcinolone acetonide for diabetic diffuse macular edema,” Ophthalmology, vol. 111, no. 2, pp. 218–225, 2004. View at Publisher · View at Google Scholar · View at Scopus